Poland· PL-100310513
Zirid
A propulsives product containing itopridi hydrochloridum, registered in Poland by Delfarma Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Itopridi hydrochloridum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A03FA
- ATC class
- Propulsives
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909997230474
- gtin05909997230481
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Itopridi hydrochloridum in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaASKETONMedochemie Ltd., Limassol
- BelgiumItoprom 50 mgPI Pharma
- SpainPROGIT 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGKappler Pharma Consult Gmbh
- FinlandProgitPro.Med.Cs Praha a.s.
- IrelandREFLAD 50 mg film-coated tabletsPRO.MED.CS Praha a.s.
- NorwayKinitoZentiva k.s.
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Itomed
- Belgium · Itoprom
- Bulgaria · Зирид, Медоприд
- Cyprus · Pridaton, Toprisan
- Czechia · Asketon, Itoprid Fmk
- Denmark · Progit
- Estonia · Astipal, Gastrix
- Spain · Progit
- Finland · Progit
- United Kingdom (Northern Ireland) · Progit
- Greece · Progit
- Croatia · Itonorm
- Hungary · Itopride Supremex
- Ireland · Reflad
- Italy · Progit
- Lithuania · Astipal, Progit
- Luxembourg · Itoprom
- Latvia · Progit
- Malta · Toprisan
- Portugal · Itomed
- Romania · Asketon
- Slovakia · Asketon, Ganaton
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/df459bca-956e-4255-a983-d079b297a154 GET /v1/drugs/df459bca-956e-4255-a983-d079b297a154?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "50 mg",
"packaging": "05909997230474 ¦ Rp ¦ 89219\n40 tabl.\n05909997230481 ¦ Rp ¦ 89220\n100 tabl.",
"substance": null,
"common_name": "Itopridi hydrochloridum",
"pl_product_id": "100310513",
"pozwolenie_nr": "54/14",
"auth_procedure": "IR",
"authorisation_validity": "2024-02-06"
}See everything about itopridi hydrochloridum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.